Is Mounjaro FDA Approved for Weight Loss?
Mounjaro received FDA approval for type 2 diabetes management, not weight loss treatment. PlexusDx provides access to compounded tirzepatide injection, a dual-action GLP-1 and GIP receptor agonist, at $289/mo month-to-month, or from $249/mo on the 6-month plan with no insurance required.
GLP-1 weight loss starts at $129/mo Provider-reviewed options. No membership fees.
See if you qualify →
Mounjaro received FDA approval for type 2 diabetes management, not weight loss treatment. PlexusDx provides access to compounded tirzepatide injection, a dual-action GLP-1 and GIP receptor agonist, at $289/mo month-to-month, or from $249/mo on the 6-month plan with no insurance required.
GLP-1 weight loss starts at $129/mo Provider-reviewed options. No membership fees.
- <1 MIN READ
Share:
Mounjaro and a History of Pancreatitis: What You Need to Know
Is Sweating a Side Effect of Mounjaro?